US Stock MarketDetailed Quotes
KTTA Pasithea Therapeutics
- 3.0900
- +0.1900+6.55%
Close Nov 29 13:00 ET
- 3.0500
- -0.0400-1.29%
Post 17:01 ET
3.91MMarket Cap-208P/E (TTM)
3.0900High2.9300Low13.07KVolume2.9900Open2.9000Pre Close39.29KTurnover1.28%Turnover RatioLossP/E (Static)1.27MShares17.400052wk High0.22P/B3.17MFloat Cap2.870052wk Low--Dividend TTM1.02MShs Float170.0000Historical High--Div YieldTTM5.52%Amplitude2.8700Historical Low3.0050Avg Price1Lot Size
About Pasithea Therapeutics Company
Pasithea Therapeutics Corp. is a biotechnology company focuses on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Steinman Lawrence J in May, 2020 and is headquartered in Miami Beach, FL.
Company Profile
SymbolKTTA
Company NamePasithea Therapeutics
Listing DateSep 15, 2021
Issue Price4.99
Founded2020
CEODr. Tiago Reis Marques
MarketNASDAQ
Employees8
Fiscal Year Ends12-31
Address1111 Lincoln Road,Suite 500
CityMiami Beach
ProvinceFlorida
CountryUnited States of America
Zip Code33139
Phone1-702-514-4174
Websitehttp://www.pasithea.com
Company Executives
- Name
- Position
- Salary
- Dr. Tiago Reis Marques
- Chief Executive Officer and Director
- 539.50K
- Daniel Schneiderman
- Chief Financial Officer and Principal Accounting Officer
- 367.20K
- Dr. Graeme Martin Currie, PhD
- Chief Development Officer
- --
- Dr. Lawrence J. Steinman, M.D.
- Executive Chairman of the Board
- 250.00K
- Simon Dumesnil
- Independent Director
- 60.00K
- Dr. Emer Leahy
- Independent Director
- 60.00K
- Alfred J Novak
- Independent Director
- 63.59K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data